By Bhanvi Satija and Pushkala Aripaka LONDON, Feb 4 (Reuters) - GSK's new CEO Luke Miels said on Wednesday that the drugmaker ...

A team of biochemists at the University of California, Santa Cruz, has developed a faster way to identify molecules in the ...

The first study on deuterium-depleted water (DDW) concluded that a higher D/H ratio inside cells can trigger cell division.

Moderna noted the FDA did not identify any specific safety concerns with the vaccine and that the rejection was inconsistent ...

For patients taking medications that don't work as expected or pharmaceutical companies struggling with clinical trial ...

AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.

Investor enthusiasm and evolving FDA pathways are accelerating rare disease drug development, with ultrarare conditions like ...

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

Kailera will launch a global Phase 2 study of ribupatide this year, while Hengrui will push the asset into Phase 3 in China.

Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of ...

Healthcare companies have been feverishly working on developing GLP-1 weight loss products in an effort to cash in on what's ...

A groundbreaking multi-stakeholder report reveals that transitioning to Non-Animal Methods (NAMs) can reduce drug development ...